Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Zika virus has pandemic potential, scientists say
aedes mosquito
"PAHO anticipates that Zika virus will continue to spread and will likely reach all countries and territories of the region where Aedes mosquitos are found."
Virus thought likely to spread across the Americas

The emerging mosquito-borne Zika virus now has 'explosive' pandemic potential, according to US scientists.

Since it was reported in Brazil in May last year, it has spread to 21 countries in the Americas (as of 23 January, 2016). This is of particular concern as there is growing evidence to suggest it could be linked with incomplete brain development in newborn babies.

It is primarily transmitted by Aedes mosquitoes, which are present in all of the Americas except Canada and continental Chile, meaning the virus is likely to spread further.

The Pan American Health Organization (PAHO) said in a statement: "PAHO anticipates that Zika virus will continue to spread and will likely reach all countries and territories of the region where Aedes mosquitos are found."

Another reason for its rapid spread, according to PAHO, is that it is new to the population of the Americas and therefore they have no immunity to it.

Whilst it generally causes only mild illness in humans, health authorities are currently investigating a possible link with microcephaly (abnormal smallness of the head) in babies.

Since Brazil reported the virus in 2015, there have been over 3,500 suspected cases - a 20-fold increase from 2010 through to 2014.

There is currently no vaccine for Zika virus. PAHO, which is a regional office of the World Health Organisation (WHO), says it is helping countries of the Americas to prepare for any possible spread through vector control, better surveillance and communication of prevention methods.

But scientists from Georgetown University, Washington DC, have said that lessons must be learnt from the Ebola epidemic. In July last year, the WHO Ebola Panel found that urgent warnings either failed to reach senior leaders, or senior leaders did not realise their significance.

Writing in the Journal of the American Medical Association, the team from Georgetown said that while the WHO has said it is supporting countries to control Zika, it 'is still not taking a leadership role in the Zika pandemic'.

An IHR emergency committee should be convened immediately, they added, saying that while Brazil, PAHO and the Centers for Disease Control have acted quickly, WHO headquarters have so far 'not been proactive'.

For the full study visit: http://jama.jamanetwork.com/article.aspx?articleID=2485361
For more information on Zika virus, see: http://www.who.int/mediacentre/factsheets/zika/en/

Become a member or log in to add this story to your CPD history

Building Great Workplaces webinars return

News Story 1
 BVA has announced a new series of its Building Great Workplaces lunchtime webinars.

Launching from 16 July, the sessions will explore patient safety, motivation, client communication and more.

Its first webinar, exploring neurodiversity in the workplace, will take place at 1pm on Thursday, 16 July. It will feature guest speakers from The Vet Project, a group which supports neurodiversity in veterinary environments.

The following three webinars take place in September, October and November.

Booking is open on the BVA website 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.